Literature DB >> 10980165

Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors.

S Bosne-David1, V Barros, S C Verde, C Portugal, H L David.   

Abstract

Subinhibitory concentrations of bacitracin, vancomycin and other inhibitors of cell wall synthesis reversed to varying extents the intrinsic resistance of Mycobacterium tuberculosis to clarithromycin. Ethambutol reversed clarithromycin resistance in all of the M. tuberculosis strains studied regardless of their susceptibility to this drug.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10980165     DOI： 10.1093/jac/46.3.391

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  11 in total

1.  Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum.

Authors:  Kevin A Nash; Yansheng Zhang; Barbara A Brown-Elliott; Richard J Wallace
Journal:  J Antimicrob Chemother       Date:  2004-12-08       Impact factor: 5.790

2.  Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.

Authors:  Sylvaine Bastian; Nicolas Veziris; Anne-Laure Roux; Florence Brossier; Jean-Louis Gaillard; Vincent Jarlier; Emmanuelle Cambau
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

3.  Mycobacterium smegmatis Erm(38) is a reluctant dimethyltransferase.

Authors:  Christian Toft Madsen; Lene Jakobsen; Stephen Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases.

Authors:  Adam A Witney; Katherine A Gould; Amber Arnold; David Coleman; Rachel Delgado; Jasvir Dhillon; Marcus J Pond; Cassie F Pope; Tim D Planche; Neil G Stoker; Catherine A Cosgrove; Philip D Butcher; Thomas S Harrison; Jason Hinds
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

5.  Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).

Authors:  Kevin A Nash
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

6.  Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.

Authors:  Weizhen Xu; Michael A DeJesus; Nadine Rücker; Curtis A Engelhart; Meredith G Wright; Claire Healy; Kan Lin; Ruojun Wang; Sae Woong Park; Thomas R Ioerger; Dirk Schnappinger; Sabine Ehrt
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

7.  Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid.

Authors:  Vanja M Bulatovic; Nancy L Wengenack; James R Uhl; Leslie Hall; Glenn D Roberts; Franklin R Cockerill; Frank Rusnak
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

8.  Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.

Authors:  Anup Aggarwal; Maloy K Parai; Nishant Shetty; Deeann Wallis; Lisa Woolhiser; Courtney Hastings; Noton K Dutta; Stacy Galaviz; Ramesh C Dhakal; Rupesh Shrestha; Shoko Wakabayashi; Chris Walpole; David Matthews; David Floyd; Paul Scullion; Jennifer Riley; Ola Epemolu; Suzanne Norval; Thomas Snavely; Gregory T Robertson; Eric J Rubin; Thomas R Ioerger; Frik A Sirgel; Ruben van der Merwe; Paul D van Helden; Peter Keller; Erik C Böttger; Petros C Karakousis; Anne J Lenaerts; James C Sacchettini
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

9.  Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections.

Authors:  Ettie M Lipner; Benjamin J Garcia; Michael Strong
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 10.  Drug Resistance Mechanisms in Mycobacterium tuberculosis.

Authors:  Juan Carlos Palomino; Anandi Martin
Journal:  Antibiotics (Basel)       Date:  2014-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.